Guardant Health · 1 day ago
Corporate Development Director - Strategy / M&A / AI
Palo Alto, CA
Full-time
Hybrid
Director/Executive
$226K/yr - $311K/yr
8+ years expGuardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. The Corporate Development Director will support all aspects of the Corporate Development function, including M&A strategy, partnerships, and business intelligence insights, while leveraging advanced analytics and emerging technologies.
BiotechnologyHealth CareHealth DiagnosticsOncologyTherapeutics
Responsibilities
Lead the transaction due diligence process, incorporating data analytics and intelligent automation to streamline evaluation and improve decision accuracy
Develop business cases supported by advanced market, valuation, and financial analytics, including scenario modeling and trend forecasting
Support the Company’s growth strategy through the identification, assessment, and execution of M&A, investments, and partnerships, guided by data-driven insights and predictive intelligence
Maintain and refine structured processes to identify and evaluate strategic opportunities across multiple business areas, integrating both quantitative and qualitative assessments
Collaborate with business leaders to identify and prioritize opportunities in a systematic and informed manner, ensuring alignment with each unit’s objectives and long-term plans
Build and maintain strong relationships across business units to sustain an ongoing flow of high-quality strategic ideas and partnership opportunities
Partner with business leaders before, during, and after M&A activity to ensure strategic fit, long-term value creation, and smooth post-deal integration
Support cross-functional teams in developing acquisition business cases and executing transactions, coordinating with Finance, Accounting, Legal, Tax, HR, and other departments to ensure seamless diligence and execution
Continuously enhance analytical capabilities, incorporating modern data platforms, automation, and AI-enabled tools to improve sourcing, valuation, and post-merger performance tracking
Qualification
Required
8+ years of experience in Corporate Development or M&A at a comparable healthcare company or Investment Bank. Experience in Product, R&D, or Marketing a plus
Undergraduate business degree, MBA, or PhD degree with a technical background in genomics, therapeutics, or oncology preferred
Demonstrated M&A partnering and equity investment experience, including negotiation, execution, and transaction closing
Intermediate or advanced understanding of the biotech, diagnostic, or medical device industry
Strong analytical and problem-solving skills, with experience using modern data analytics, automation, and AI-assisted decision tools to support strategy and valuation work
Ability to structure and manage complex projects and processes with multiple stakeholders at all levels, including Executive and senior leadership
Excellent communication and presentation skills, with the ability to convey data-driven insights clearly and persuasively
Ability to travel, both domestically and internationally, 10%–20% to conferences and meetings
Company
Guardant Health
Guardant Health is a precision oncology company that uses blood tests, data sets, and analytics to provide treatment to cancer patients.
1001-5000 employees
H1B Sponsorship
Guardant Health has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (38)
2024 (50)
2023 (40)
2022 (72)
2021 (57)
2020 (29)
Funding
Current Stage
Public CompanyTotal Funding
$2.53BKey Investors
Baillie GiffordSoftBank Vision FundOrbiMed
2025-11-05Post Ipo Equity· $284.4M
2025-11-05Post Ipo Debt· $350M
2023-12-21Post Ipo Equity· $90.7M
Leadership Team
AmirAli Talasaz
Co-founder and Co-Chief Executive Officer
Helmy Eltoukhy
Chairman and Co-Chief Executive Officer
Recent News
2026-01-03
felicis.com
2025-12-30
Company data provided by crunchbase